Post-Transplant Lymphoproliferative Disorder, Early Lesion

Known as: Non-Neoplastic Post-Transplant Lymphoproliferative Disorder, PTLD (Polyclonal), Post-transplant lymphoproliferative disorder (Polyclonal), NOS 
A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by the lack of tissue… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2012
01219722012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Since they were first described in 1993, it was found that recombinant variable fragments (rVHHs) of heavy-chain antibodies… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The kinetics of IL-1 (alpha and beta) production after Pseudomonas aeruginosa corneal infection was examined in susceptible… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
The bcl-2 gene belongs to a class of oncogenes involved in the inhibition of apoptosis. Most follicular lymphomas are associated… (More)
Is this relevant?
1997
1997
A frequently fatal complication of organ transplantation, post-transplant lymphoproliferative disorder (PTLD) develops in 2%-6… (More)
Is this relevant?
1992
1992
Previous reports of patients with persistent polyclonal B lymphocytosis have found associations with female sex, cigarette… (More)
Is this relevant?